Goldstream Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,500
Closed -$476K 15
2022
Q3
$476K Buy
8,500
+4,500
+113% +$252K 0.37% 8
2022
Q2
$207K Buy
+4,000
New +$207K 0.18% 10
2022
Q1
Sell
-30,161
Closed -$3.57M 37
2021
Q4
$3.57M Buy
+30,161
New +$3.57M 0.88% 10